Total Payments
$2.2M
2024 Payments
$412,620
Companies
5
Transactions
53
Payment Breakdown by Category
Other$1.9M (88.7%)
Consulting$245,579 (11.2%)
Research$975.00 (0.0%)
Food & Beverage$905.15 (0.0%)
Travel$288.47 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.9M | 19 | 88.7% |
| Consulting Fee | $245,579 | 23 | 11.2% |
| Unspecified | $975.00 | 1 | 0.0% |
| Food and Beverage | $905.15 | 5 | 0.0% |
| Travel and Lodging | $288.47 | 5 | 0.0% |
Payments by Type
General
$2.2M
52 transactions
Research
$975.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $2.2M | 43 | $0 (2024) |
| Millennium Pharmaceuticals, Inc. | $9,678 | 3 | $0 (2017) |
| SANOFI US SERVICES INC. | $7,272 | 3 | $0 (2018) |
| APO-PHARMA INC. | $6,500 | 1 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $3,575 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $412,620 | 8 | Agios Pharmaceuticals, Inc. ($412,620) |
| 2023 | $429,902 | 8 | Agios Pharmaceuticals, Inc. ($429,902) |
| 2022 | $426,264 | 7 | Agios Pharmaceuticals, Inc. ($426,264) |
| 2021 | $16,250 | 1 | Agios Pharmaceuticals, Inc. ($16,250) |
| 2020 | $425,965 | 8 | Agios Pharmaceuticals, Inc. ($424,990) |
| 2019 | $427,826 | 10 | Agios Pharmaceuticals, Inc. ($425,226) |
| 2018 | $39,826 | 7 | Agios Pharmaceuticals, Inc. ($32,554) |
| 2017 | $16,178 | 4 | Millennium Pharmaceuticals, Inc. ($9,678) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $35.00 | General |
| 07/17/2024 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $45.00 | General |
| 07/10/2024 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 06/20/2024 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Dividend, profit or other return on investment | $270,000.00 | General |
| 06/20/2024 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Stock, stock option, or any other ownership interest | $90,000.00 | General |
| 06/06/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.67 | General |
| 05/15/2024 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 02/21/2024 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 12/13/2023 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $102.00 | General |
| 10/18/2023 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 07/26/2023 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 06/13/2023 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Dividend, profit or other return on investment | $269,772.34 | General |
| 06/13/2023 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Stock, stock option, or any other ownership interest | $89,982.28 | General |
| 05/03/2023 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 03/15/2023 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $45.00 | General |
| 02/08/2023 | Agios Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $17,500.00 | General |
| 11/09/2022 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17,500.00 | General |
| 08/24/2022 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,250.00 | General |
| 06/23/2022 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,250.00 | General |
| 06/21/2022 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Dividend, profit or other return on investment | $269,923.92 | General |
| 06/21/2022 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Stock, stock option, or any other ownership interest | $89,999.92 | General |
| 03/30/2022 | Agios Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $90.00 | General |
| 03/03/2022 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,250.00 | General |
| 03/03/2021 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,250.00 | General |
| 11/12/2020 | Agios Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,250.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Open-label, Multiple Ascending Dose Study to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria | Alexion Pharmaceuticals, Inc. | $975.00 | 1 |
About Dr. David Scadden, MD
Dr. David Scadden, MD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609829852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Scadden, MD has received a total of $2.2M in payments from pharmaceutical and medical device companies, with $412,620 received in 2024. These payments were reported across 53 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.9M).
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Boston, MA
- Active Since 05/18/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609829852
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $7,272
- IDHIFA (Drug) $25.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
Internal Medicine $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Internal Medicine $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Internal Medicine $2.5M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Dr. David Kuter, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M